Menu
ETF
Annual · values202520242023202220212020201920182017201620152014
Operating Cash Flow-13.69 M USD-8.50 M USD-9.14 M USD-8.41 M USD-2.95 M USD-3.51 M USD-4.62 M USD-2.55 M USD-4.67 M USD-6.56 M USD-2.53 M USD-9.09 M USD
Depreciation & Amortization626000 USD587000 USD595000 USD429000 USD105653 USD126211 USD122736 USD513029 USD554361 USD367611 USD320301 USD413773 USD
Stock-Based Compensation9.85 M USD10.26 M USD10.62 M USD10.58 M USD9.36 M USD3.17 M USD1.33 M USD560973 USD768682 USD1.37 M USD1.31 M USD1.50 M USD
Capital Expenditures93000 USD34000 USD366000 USD2.38 M USD1.40 M USD70896 USD29486 USD265482 USD81577 USD410184 USD
Cash Flow from Investing-93000 USD74000 USD19.77 M USD-22.09 M USD-1.40 M USD-70896 USD-29486 USD-265482 USD-81577 USD-410184 USD-153151 USD-123912 USD
Cash Flow from Financing14.76 M USD297000 USD81000 USD220000 USD547411 USD17.34 M USD24.03 M USD9.92 M USD-58946 USD9.88 M USD1.00 M USD2.71 M USD
Dividends Paid0 USD0 USD0 USD0 USD0 USD0 USD0 USD0 USD0 USD0 USD
Stock Buybacks
Free Cash Flow-13.78 M USD-8.53 M USD-9.51 M USD-10.79 M USD-4.34 M USD-3.58 M USD-4.65 M USD-2.81 M USD-4.76 M USD-6.97 M USD

Stereotaxis Inc. is a cutting-edge medical technology company that specializes in robotic systems for minimally invasive surgery. The company's primary focus is on the development and commercialization of robotic navigation technologies designed to enhance the precision, safety, and efficiency of procedures within the cardiac arrhythmia treatment sector. Stereotaxis' flagship product, the Niobe Magnetic Navigation System, enables physicians to maneuver catheters with a high degree of accuracy, using magnetic fields to decrease potential complications associated with traditional manual techniques. This technology significantly impacts the healthcare sector, particularly hospitals and medical centers specializing in interventional cardiology, by improving patient outcomes and operational workflows. Based in St. Louis, Missouri, Stereotaxis plays a significant role in advancing the field of robotic surgery, contributing to the broader medical device market's growth and innovation.